Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Whole genome sequencing recommended to improve treatment targeting for leukaemia patients
Researchers have identified a new gene mutation causing treatment resistance in acute lymphoblastic leukaemia. The…
RethiNKing which immune cells are the best weapon against lung cancer
Immune cells called ‘natural killer’ (NK) cells could be a powerful weapon for fighting lung…
New research sheds light on multi-organ adverse events from immunotherapy
New international research in the September 2020 issue of JNCCN—Journal of the National Comprehensive Cancer Network…
Supportive care for cancer patients remains inadequate
Pain relief and other forms of supportive care for cancer patients are insufficient, researchers report at the ESMO ASIA 2016…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.